Utah Medical Products Inc (UTMD) stock

UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/306% below fair value

$71.97−1.66 (-2.25%)

Close on Nov 13, 2026Market cap $229.14MP/E 21.5Yield –

Utah Medical Products ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Utah Medical Products has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Utah Medical Products's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is UTMD.

Gross margin57.7% · median 63.6%

Operating margin29.9% · median -1.3%

Advertisement
300 × 250

See a number that looks wrong?